HungaroTrial CRO

HungaroTrial is a leading regional Contract Research Organization (CRO) specializing in clinical trial management across Central and Eastern Europe (CEE), with a growing global footprint in the United States and the Asia-Pacific region. Founded in 1999, the company provides full-service clinical development support for Phase I-IV trials, catering to pharmaceutical, biotechnology, and medical device companies. They are particularly recognized for their expertise in rapid study start-up, high patient recruitment rates, and a deep understanding of regional regulatory landscapes. The company operates a robust network of local offices in over 10 countries, including Hungary, Poland, Romania, and the Czech Republic, and recently expanded with operational hubs in Atlanta, USA, and Seoul, South Korea. HungaroTrial's leadership team includes a high density of medical doctors (14+ MDs), ensuring that clinical projects are managed with strong scientific and medical oversight. Their service portfolio includes project management, site selection, monitoring, regulatory affairs, pharmacovigilance, and medical writing. With over 25 years of experience, HungaroTrial has managed more than 380 clinical trials and enrolled over 15,000 patients. They maintain a strong focus on therapeutic areas such as oncology, which represents their largest area of expertise, as well as cardiology, CNS, and rare diseases. The company is ISO 9001:2015 certified, reflecting a commitment to high-quality management standards in the highly regulated clinical research industry.